UL Solution For 2024 Anticipates Mid-To-High Single-Digit Organic Revenue Growth, Improved Adjusted EBITDA Margin And Capital Expenditures At 8.0-8.5% Of Revenue

Benzinga
2024-11-05

Full-Year 2024 Outlook

The Company's key points on 2024 outlook include:

  • Increasing to mid-to-high single digit constant currency, organic revenue growth
  • Q4 constant currency, organic revenue growth expected to be in the mid-to-high single digit range
  • Reiterating full-year Adjusted EBITDA margin improvement
  • Capital expenditures expected to be 8.0 to 8.5% of revenue
  • Continuing to pursue acquisitions and portfolio refinements

The Company's 2024 outlook is based on a number of assumptions that are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company's expectations may change. There can be no assurance that the Company will achieve the results expressed by this outlook.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10